Emily L. Mueller

Emily L. Mueller

Auto-generated profile, based on publicly available information

Emily L. Mueller

Indiana University, Indianapolis, Indiana, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2014 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
EMEmily L. Mueller
Emily L. Mueller
ASAmber Sabbatini
Amber Sabbatini
AGAchamyeleh Gebremariam
Achamyeleh Gebremariam
RMRajen Mody
Rajen Mody
LSLillian Sung
Lillian Sung
MMMichelle L. Macy
Michelle L. Macy

17 July 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
EMEmily L. Mueller
Emily L. Mueller
ACAnneli R. Cochrane
Anneli R. Cochrane
WBWilliam E. Bennett
William E. Bennett
ACAaron E. Carroll
Aaron E. Carroll

10 May 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EMEmily L. Mueller
Emily L. Mueller
KWKelly J. Walkovich
Kelly J. Walkovich
RMRajen Mody
Rajen Mody
AGAchamyeleh Gebremariam
Achamyeleh Gebremariam
MDMatthew M. Davis
Matthew M. Davis
Fever and neutropenia (FN) is a common complication of pediatric cancer treatment, but hospital utilization patterns for this condition are not well described. Data were analyzed from the Kids’ Inpatient Database (KID), an all-payer US hospital database, for 2009. Pediatric FN patients were identified using: age ≤19 years, urgent or emergent admit type, non-transferred, and a combination of ICD-9-CM codes for fever and neutropenia. Sampling weights were used to permit national inferences. Pediatric cancer patients accounted for 1.5 % of pediatric hospital discharges in 2009 (n = 110,967), with 10.1 % of cancer-related discharges meeting FN criteria (n = 11,261). Two-fifths of FN discharges had a “short length of stay” (SLOS) of ≤3 days, which accounted for approximately $65.5 million in hospital charges. Upper respiratory infection (6.0 %) and acute otitis media (AOM) (3.7 %) were the most common infections associated with SLOS. Factors significantly associated with SLOS included living in the Midwest region (OR = 1.65, 1.22–2.24) or West region (OR 1.54, 1.11–2.14) versus Northeast, having a diagnosis of AOM (OR = 1.39, 1.03–1.87) or viral infection (OR = 1.63, 1.18–2.25) versus those without those comorbidities, and having a soft tissue sarcoma (OR = 1.47, 1.05–2.04), Hodgkin lymphoma (OR = 2.33, 1.62–3.35), or an ovarian/testicular tumor (OR = 1.76, 1.05–2.95) compared with patients without these diagnoses. FN represents a common precipitant for hospitalizations among pediatric cancer patients. SLOS admissions are rarely associated with serious infections, but contribute substantially to the burden of hospitalization for pediatric FN.

16 March 2022 in JMIR Cancer
Verified
Journal Article
Open access
EMEmily L Mueller
Emily L Mueller
ACAnneli R Cochrane
Anneli R Cochrane
MCMadison E Campbell
Madison E Campbell
SNSarah Nikkhah
Sarah Nikkhah
AMAndrew D Miller
Andrew D Miller
Background: Caregivers face new challenges and tasks when their child is diagnosed with cancer, which can be overwhelming. Mobile technology has the capacity to provide immediate support at their fingertips to aid in tracking symptoms, managing medication, and planning for emergencies. Objective: The objective of this study is to engage directly with end users and proxies to co-design and create a mobile technology app to support caregivers in the medical management of their child with cancer. Methods: We engaged directly with caregivers of children with cancer and pediatric oncology nurse coordinators (proxy end users) to co-design and create the prototype of the Cope 360 mobile health app. Alpha testing was accomplished by walking the users through a series of predetermined tasks that encompassed all aspects of the app including tracking symptoms, managing medications, and planning or practicing for a medical emergency that required seeking care in the emergency department. Evaluation was accomplished through recorded semistructured interviews and quantitative surveys to capture demographic information and measure the system usability score. Interviews were transcribed and analyzed iteratively using NVivo (version 12; QSR International). Results: This study included 8 caregivers (aged 33-50 years) of children with cancer, with most children receiving chemotherapy, and 6 nurse coordinators, with 3 (50%) of them having 11 to 20 years of nursing experience. The mean system usability score given by caregivers was 89.4 (95% CI 80-98.8). Results were grouped by app function assessed with focus on specific attributes that were well received and those that required refinement. The major issues requiring refinement included clarity in the medical information and terminology, improvement in design of tasks, tracking of symptoms including adjusting the look and feel of certain buttons, and changing the visual graph used to monitor symptoms to include date anchors. Conclusions: The Cope 360 app was well received by caregivers of children with cancer but requires further refinement for clarity and visual representation. After refinement, testing among caregivers in a real-world environment is needed to finalize the Cope 360 app before its implementation in a randomized controlled trial.

25 June 2018 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
EMEmily L. Mueller
Emily L. Mueller
EPElyse R. Park
Elyse R. Park
AKAnne C Kirchhoff
Anne C Kirchhoff
KKKaren Kuhlthau
Karen Kuhlthau
Paul NathanPaul Nathan
Paul Nathan
KDKaren Donelan
Karen Donelan

18 April 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
CHCristiana Hentea
Cristiana Hentea
ECErika R. Cheng
Erika R. Cheng
NBNerissa S. Bauer
Nerissa S. Bauer
EMEmily L. Mueller
Emily L. Mueller